Literature DB >> 29761347

Negligible impact of differential item functioning between Black and White dialysis patients on the Kidney Disease Quality of Life 36-item short form survey (KDQOLTM-36).

John D Peipert1,2,3, Peter Bentler4, Kristi Klicko5, Ron D Hays6.   

Abstract

PURPOSE: Black dialysis patients report better health-related quality of life (HRQOL) than White patients, which may be explained if Black and White patients respond systematically differently to HRQOL survey items.
METHODS: We examined differential item functioning (DIF) of the Kidney Disease Quality of Life 36-item (KDQOLTM-36) Burden of Kidney Disease, Symptoms and Problems with Kidney Disease, and Effects of Kidney Disease scales between Black (n = 18,404) and White (n = 21,439) dialysis patients. We fit multiple group confirmatory factor analysis models with increasing invariance: a Configural model (invariant factor structure), a Metric model (invariant factor loadings), and a Scalar model (invariant intercepts). Criteria for invariance included non-significant χ2 tests, > 0.002 difference in the models' CFI, and > 0.015 difference in RMSEA and SRMR. Next, starting with a fully invariant model, we freed loadings and intercepts item-by-item to determine if DIF impacted estimated KDQOLTM-36 scale means.
RESULTS: ΔCFI was 0.006 between the metric and scalar models but was reduced to 0.001 when we freed intercepts for the burdens and symptoms and problems of kidney disease scales. In comparison to standardized means of 0 in the White group, those for the Black group on the Burdens, Symptoms and Problems, and Effects of Kidney Disease scales were 0.218, 0.061, and 0.161, respectively. When loadings and thresholds were released sequentially, differences in means between models ranged between 0.001 and 0.048.
CONCLUSION: Despite some DIF, impacts on KDQOLTM-36 responses appear to be minimal. We conclude that the KDQOLTM-36 is appropriate to make substantive comparisons of HRQOL between Black and White dialysis patients.

Entities:  

Keywords:  Differential item functioning; Health-related quality of life; KDQOL-36; Measurement invariance

Mesh:

Year:  2018        PMID: 29761347     DOI: 10.1007/s11136-018-1879-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  14 in total

1.  KDQOL-36 and the interdisciplinary team.

Authors:  Renata Sledge
Journal:  Nephrol News Issues       Date:  2010-06

2.  Power and sensitivity of alternative fit indices in tests of measurement invariance.

Authors:  Adam W Meade; Emily C Johnson; Phillip W Braddy
Journal:  J Appl Psychol       Date:  2008-05

3.  Identification of Confirmatory Factor Analysis Models of Different Levels of Invariance for Ordered Categorical Outcomes.

Authors:  Hao Wu; Ryne Estabrook
Journal:  Psychometrika       Date:  2016-07-11       Impact factor: 2.500

4.  Psychometric Properties of the Kidney Disease Quality of Life 36-Item Short-Form Survey (KDQOL-36) in the United States.

Authors:  John D Peipert; Peter M Bentler; Kristi Klicko; Ron D Hays
Journal:  Am J Kidney Dis       Date:  2017-11-08       Impact factor: 8.860

5.  Measurement invariance and general population reference values of the PROMIS Profile 29 in the UK, France, and Germany.

Authors:  Felix Fischer; Chris Gibbons; Joël Coste; Jose M Valderas; Matthias Rose; Alain Leplège
Journal:  Qual Life Res       Date:  2018-01-19       Impact factor: 4.147

6.  Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Antonio Alberto Lopes; Jennifer L Bragg-Gresham; Sudtida Satayathum; Keith McCullough; Trinh Pifer; David A Goodkin; Donna L Mapes; Eric W Young; Robert A Wolfe; Philip J Held; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

7.  Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Donna L Mapes; Jennifer L Bragg-Gresham; Jürgen Bommer; Shunichi Fukuhara; Patricia McKevitt; Björn Wikström; Antonio Alberto Lopes
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

8.  Racial differences in health-related quality of life among hemodialysis patients.

Authors:  Mark Unruh; Dana Miskulin; Guofen Yan; Ron D Hays; Robert Benz; John W Kusek; Klemens B Meyer
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

9.  Measurement invariance of the kidney disease and quality of life instrument (KDQOL-SF) across veterans and non-veterans.

Authors:  Karen L Saban; Fred B Bryant; Domenic J Reda; Kevin T Stroupe; Denise M Hynes
Journal:  Health Qual Life Outcomes       Date:  2010-10-25       Impact factor: 3.186

10.  Social support and health-related quality of life in black and white dialysis patients.

Authors:  G S Tell; M B Mittelmark; B Hylander; S A Shumaker; G Russell; J M Burkart
Journal:  ANNA J       Date:  1995-06
View more
  4 in total

1.  Kidney Disease Quality of Life 36-Item Short Form Survey (KDQOL-36) Normative Values for the United States Dialysis Population and New Single Summary Score.

Authors:  John D Peipert; Devika Nair; Kristi Klicko; Dorian R Schatell; Ron D Hays
Journal:  J Am Soc Nephrol       Date:  2019-03-21       Impact factor: 10.121

2.  Differential item functioning of the CAHPS® In-Center Hemodialysis Survey.

Authors:  Claude M Setodji; John D Peipert; Ron D Hays
Journal:  Qual Life Res       Date:  2019-07-26       Impact factor: 4.147

3.  Using patient-reported outcome measures (PROMs) to promote quality of care in the management of patients with established kidney disease requiring treatment with haemodialysis in the UK (PROM-HD): a qualitative study protocol.

Authors:  Nicola Elzabeth Anderson; Melanie Calvert; Paul Cockwell; Mary Dutton; Olalekan Lee Aiyegbusi; Derek Kyte
Journal:  BMJ Open       Date:  2018-10-28       Impact factor: 2.692

4.  Problems with analyses and interpretation of data in "use of the KDQOL-36™ for assessment of health-related quality of life among dialysis patients in the United States".

Authors:  Ron D Hays; John D Peipert; Joel D Kallich
Journal:  BMC Nephrol       Date:  2019-12-03       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.